---
title: The Promise of Antiviral COVID-19 Treatment Pills
description: As the COVID-19 continues, the pharmaceuticals industry is hard at work developing targeted antivirals that can be delivered in capsule form. Check it out!
image: https://blog.lyfegroup.com/hubfs/50-mini-portada.jpg
---

[![Logo-LyfeGroup-blue](https://blog.lyfegroup.com/hs-fs/hubfs/Logo-LyfeGroup-blue.png?width=800&height=169&name=Logo-LyfeGroup-blue.png)](https://blog.lyfegroup.com/)

[![Logo-LyfeGroup-blue](https://blog.lyfegroup.com/hubfs/Logo-LyfeGroup-blue.png)](https://blog.lyfegroup.com/)

- [Company](https://capscanada.com/company/?_gl=1*lcqm70*_gcl_au*NjgyNjM5Njk4LjE3Mzc0OTIzMzI.)
- [Contact](https://capscanada.com/contact/?_gl=1*lcqm70*_gcl_au*NjgyNjM5Njk4LjE3Mzc0OTIzMzI.)
- [Jobs](https://capscanada.com/careers/?_gl=1*lcqm70*_gcl_au*NjgyNjM5Njk4LjE3Mzc0OTIzMzI.)
- [Industries](https://capscanada.com/markets/) 
    - [Pharmaceutical](https://capscanada.com/pharmaceuticals/)
    - [Nutraceutical](https://capscanada.com/nutraceuticals/)
- [Empty Capsules](https://capscanada.com/empty-capsules/) 
    - [K-CAPS HPMC Capsules](https://capscanada.com/hpmc-capsules/)
    - [K-CAPS® Delayed-Release Capsules](https://capscanada.com/k-caps-delayed-release-capsules/)
    - [AR-CAPS® Acid Resistant Capsules](https://capscanada.com/acid-resistant-capsules/)
    - [PET-CAPS® Veterinary Capsules/](https://capscanada.com/pet-caps-capsules-for-vet-pharma/)
    - [G-CAPS Gelatin Capsules](https://capscanada.com/gelatin-capsules/)
    - [LQ-CAPS® Liquid Formulation Capsules](https://capscanada.com/liquid-formulation-capsules/)
    - [FM-CAPS® Clinical Trial Capsules](https://capscanada.com/clinical-trials-capsules/)
    - [Flavored Empty Capsules®](https://capscanada.com/flavors-taste-masking/)
- [Services](https://capscanada.com/services/) 
    - [Technical Services](https://capscanada.com/technical-service/)
    - [Formulation Assistance](https://capscanada.com/formulation-assistance/)
    - [Regulatory Compliance](https://capscanada.com/regulatory-compliance/)
    - [Custom Banding](https://capscanada.com/custom-banding-formulation-creation/)
    - [Tamping Simulator Tool](https://capscanada.com/tamping-simulator-tool/)
    - [Stability Disintegration Testing](https://capscanada.com/stability-disintegration-testing/)
    - [Clean Label Consulting](https://capscanada.com/clean-label-consulting/)
- [Build your own capsule](https://capscanada.com/capsule-customizer/) 
    - [Capsule Colors](https://capscanada.com/capsule-colors/)
    - [Capsule Printing](https://capscanada.com/capsule-printing/)
    - [Capsule Finishes](https://capscanada.com/capsule-finishes/)
    - [Capsule Simulator](https://capscanada.com/capsule-customizer/)
    - [Capsule Flavors](https://capscanada.com/taste-masking-technologies/)
    - [Capsule Sizes](https://capscanada.com/capsule-sizes/)
    - [Capsule Banding Kits](https://capscanada.com/banding-kits/)
- Knowledge center
  
    - [Library](https://blog.lyfegroup.com/digital-library)
    - [Blog](https://blog.lyfegroup.com)
    - [News and Events](https://capscanada.com/news-and-events/)
    - [Faqs](https://capscanada.com/faqs/)

[Buy Now](https://marketplace.hubspot.com/products/worductdia/dew-template-pack?__hstc=45270139.0b308accccbbca451e1f1ec8034b1b29.1584524736818.1584524736818.1584524736818.1&__hssc=45270139.1.1584524736818&__hsfp=2870217423)

BUY

- [Get Free Template Pack](https://marketplace.hubspot.com/products/worductdia/clear-theme)
- [Get Premium Template Pack](https://marketplace.hubspot.com/products/worductdia/dew-template-pack?__hstc=45270139.cac4034aa5723604ba54c9cb51fff60e.1576911208416.1576911208416.1576911208416.1&__hssc=45270139.1.1576911208417&__hsfp=3806854726)

[![Lyfe Group Logo](https://blog.lyfegroup.com/hs-fs/hubfs/Logo-LyfeGroup-blue.png?width=800&height=169&name=Logo-LyfeGroup-blue.png "Lyfe Group Logo")](https://lyfegroup.com/)

- [Industries](https://lyfegroup.com/markets/) 
    - [Pharmaceutical](https://lyfegroup.com/pharmaceuticals/)
    - [Nutraceutical](https://lyfegroup.com/nutraceuticals/)
- [Empty Capsules](https://lyfegroup.com/empty-capsules/) 
    - [K-CAPS HPMC Capsules](https://lyfegroup.com/hpmc-capsules/)
    - [K-CAPS® Delayed Release Capsules](https://lyfegroup.com/k-caps-delayed-release-capsules/)
    - [AR-CAPS® Acid Resistant Capsules](https://lyfegroup.com/acid-resistant-capsules/)
    - [PET-CAPS® Veterinary Capsules](https://lyfegroup.com/pet-caps-capsules-for-vet-pharma/)
    - [G-CAPS Gelatin Capsules](https://lyfegroup.com/gelatin-capsules/)
    - [LQ-CAPS® Liquid Formulation Capsules](https://lyfegroup.com/liquid-formulation-capsules/)
    - [FM-CAPS® Clinical Trial Capsules](https://lyfegroup.com/clinical-trials-capsules/)
    - [Flavored Empty Capsules®](https://lyfegroup.com/flavors-taste-masking/)
- [Services](https://lyfegroup.com/services/) 
    - [Technical Services](https://lyfegroup.com/technical-service/)
    - [Formulation Assistance](https://lyfegroup.com/formulation-assistance/)
    - [Regulatory Compliance](https://lyfegroup.com/regulatory-compliance/)
    - [Custom Banding](https://lyfegroup.com/custom-banding-formulation-creation/)
    - [Tamping Simulator Tool](https://lyfegroup.com/tamping-simulator-tool/)
    - [Stability Disintegration Testing](https://lyfegroup.com/stability-disintegration-testing/)
    - [Clean Label Consulting](https://lyfegroup.com/clean-label-consulting/)
    - [Capsule Gauge](https://lyfegroup.com/capsule-gauge/)
- [Build your own capsule](https://lyfegroup.com/capsule-customizer/) 
    - [Capsule Colors](https://lyfegroup.com/capsule-colors/)
    - [Capsule Printing](https://lyfegroup.com/capsule-printing/)
    - [Capsule Finishes](https://lyfegroup.com/capsule-finishes/)
    - [Capsule Simulator](https://lyfegroup.com/capsule-customizer/)
    - [Capsule Flavors](https://lyfegroup.com/taste-masking-technologies/)
    - [Capsule Sizes](https://lyfegroup.com/capsule-sizes/)
    - [Capsule Banding Kits](https://lyfegroup.com/banding-kits/)
- Knowledge Center 
    - [Library](https://blog.lyfegroup.com/digital-library)
    - [Blog](https://blog.lyfegroup.com)
    - [News and Events](https://lyfegroup.com/news-and-events/)
    - [Faqs](https://lyfegroup.com/faqs/)

- [Blog](https://blog.lyfegroup.com)
- The Promise of Antiviral COVID-19 Treatment Pills

 CapsCanada is now Lyfe Group. We have a new image, but the same team, products and quality as always. | CapsCanada is now Lyfe Group. We have a new image, but the same team, products and quality as always. | CapsCanada is now Lyfe Group. We have a new image, but the same team, products and quality as always. | CapsCanada is now Lyfe Group. We have a new image, but the same team, products and quality as always. | CapsCanada is now Lyfe Group. We have a new image, but the same team, products and quality as always. | CapsCanada is now Lyfe Group. We have a new image, but the same team, products and quality as always. | CapsCanada is now Lyfe Group. We have a new image, but the same team, products and quality as always. | CapsCanada is now Lyfe Group. We have a new image, but the same team, products and quality as always. | CapsCanada is now Lyfe Group. We have a new image, but the same team, products and quality as always. |

![50-portada-768-x-300](https://blog.lyfegroup.com/hubfs/50-portada-768-x-300.jpg "50-portada-768-x-300")

- [Market Trends](https://blog.lyfegroup.com/tag/Market-Trends)

<https://blog.lyfegroup.com/the-promise-of-antiviral-covid-19-treatment-pills>

# The Promise of Antiviral COVID-19 Treatment Pills

Posted by [CapsCanada](https://blog.lyfegroup.com/author/capscanada) on Nov 11, 2021, 11:30:00 a.m.

As the COVID-19 pandemic continues, the pharmaceuticals industry is hard at work developing targeted antivirals that can be delivered in capsule form. Clinical trials are currently underway. The goal: Develop an oral treatment regimen that can be prescribed as soon as a patient tests positive for COVID-19 and then taken at home.

To be clear, these pharmaceuticals are not meant as a substitute for vaccination. But the reality is, in spite of widespread availability of vaccine, some people either refuse or cannot get the vaccine, and, although not common, “break-through” COVID-19 cases are happening in fully-vaccinated people. Clearly there is a need for more treatment options.

## **Three drugs to watch**

 

There are currently three drugs under development that are garnering the most attention:

- **Molnupiravir**, from Merck & Co. and Ridgeback Biotherapeutics. Based on clinical trial results, molnupiravir is the first oral antiviral that has been found to be effective against COVID-19, reducing the risk of hospitalization and death by about 50%. In december 2021, [FDA](https://www.nytimes.com/2021/12/23/business/pill-covid.html)[granted emergency authorization to this capsule](https://www.nytimes.com/2021/12/23/business/pill-covid.html) under special conditions. 
  
  Molnupiravir, which was only tested on unvaccinated people who had mild to moderate cases of COVID-19 and had at least one risk factor for developing a severe case of the disease, also appears to be effective against COVID-19 variants such as Delta and Mu.
- **PF-07321332**, from Pfizer, which is being tested in combination with a low dose of ritonavir, another antiviral. It is believed that co-administration with ritonavir will enable PF-07321332 to remain in the body combatting the coronavirus for a longer period of time.
- **AT-527**, from Roche and Atea Pharmaceuticals. The latest news on this drug is that Phase 3 clinical trials have been delayed until the second half of 2022 due to disappointing Phase 2 clinical trial One possible explanation might be the design of the clinical trial itself, which included people who had been vaccinated against COVID-19.

[![In our guide, you will discover how color customization can make the difference for your product](https://no-cache.hubspot.com/cta/default/7215323/83d6261e-98b2-43aa-85f1-1ab28d11c323.png)](https://cta-redirect.hubspot.com/cta/redirect/7215323/83d6261e-98b2-43aa-85f1-1ab28d11c323)

## **How these antivirals work**

 

Antivirals in general are not new. In fact, they are already being used against many viruses, including herpes, HIV, Ebola and the common flu.

Antivirals work by suppressing or interfering with the virus’ ability to replicate in human cells. Normally, as a virus multiplies the person gets increasingly ill. Disrupting this ability to multiple will in effect kill the virus.

In the case of these COVID-19 antivirals, Molnupiravir works by introducing RNA-like building blocks into the virus’ RNA genome that cause defects (i.e., “mutations”) when the cells attempt to replicate. Pfizer’s drug is a protease inhibitor designed to block the activity of the main protease enzyme that COVID-19 needs to replicate. AT-527 is designed to interfere with the virus’ RNA polymerase, which is a key component in the virus’ replication machinery.

***Keep learning about capsule technology trends...***

- [Are Liquid Filled Capsules the Right Delivery Method for Your Formula?](https://blog.lyfegroup.com/discover-if-liquid-filled-capsules-are-the-right-delivery-method-for-your-formula)
- [Vitamin and Supplements Trends](https://blog.capscanada.com/vitamin-and-supplement-the-trends-were-seeing-in-the-marketplace)
- [Clinical Trial Capsules: 4 Key Features to Look For](https://blog.capscanada.com/clinical-trial-capsules-key-features-to-look-for)

## **Having a COVID-19 treatment in capsule form can be a game changer**

 

As of this writing, all of the antivirals approved for treating COVID-19, including Gilead Sciences’ Veklury (remdesivir) and the monoclonal antibodies, must be administered intravenously in a medical setting. Consequently, none of these existing treatments are meant for early, widespread use or for people with mild or moderate symptoms.

In contrast, the oral antivirals under development are specifically meant for early, widespread use. They are designed to:

- **Reduce hospitalizations and deaths** – This, of course, is the biggest benefit.
- **Provide treatment at home –** These oral antivirals are all home-based
- **Reduce the cost of treatment current IV-based options** – For example, if molnupiravir receives either emergency use or full approval, the Biden administration has agreed to purchase 1.7 million treatment courses at $700 each. In comparison, monoclonal antibody treatment costs $1,250 to $2,100 per infusion, excluding treatment fees charged by the infusion center.
- **Reduce the spread of disease** – In September Pfizer also began a clinical trial testing to see if PF-07321332 can prevent healthy adults who live in the same household as someone with a confirmed symptomatic COVID-19 infection from getting ill.
- **Use existing pharmacy networks** – Treatment can be made easily available via prescription. With no need for temperature controls or other special measures, capsules are easy to transport and dispense.

[![In our study, you will find more about dog preferences in lavor](https://no-cache.hubspot.com/cta/default/7215323/b622b5ce-23d4-4406-96e0-121978905404.png)](https://cta-redirect.hubspot.com/cta/redirect/7215323/b622b5ce-23d4-4406-96e0-121978905404)

**Conclusion**

These are very positive and exciting developments in the on-going battle against the COVID-19 pandemic…and excellent examples of the value and benefits of capsules as a convenient, easy-to-distribute dosage form.

 

[![Contact Us](https://no-cache.hubspot.com/cta/default/7215323/7f37dd4c-36a6-44d0-a1d4-56b2c007cad6.png)](https://cta-redirect.hubspot.com/cta/redirect/7215323/7f37dd4c-36a6-44d0-a1d4-56b2c007cad6)

CapsCanada, a [Lyfe Group](https://lyfegroup.com/) company, contributes to a broader life sciences ecosystem that serves the nutraceutical and pharmaceutical industries. Lyfe Group delivers value through high-performance empty capsule solutions, operational support, and global supply expertise, helping manufacturers accelerate product readiness and market reach.

 Topics: [Market Trends](https://blog.lyfegroup.com/tag/market-trends)

## Related blogs

[![Peptide supplements: What the boom means for manufacturers | Lyfe Group Blog](https://blog.lyfegroup.com/hubfs/image_blog-The-Peptide-Supplement-Boom-What-It-Means-for-Nutraceutical-Manufacturers.jpg)](https://blog.lyfegroup.com/peptide-supplements-what-the-boom-means-for-manufacturers-lyfe-group-blog)

### [The Peptide Supplement Boom: What It Means for Nutraceutical Manufacturers](https://blog.lyfegroup.com/peptide-supplements-what-the-boom-means-for-manufacturers-lyfe-group-blog)

**The rapid growth of collagen and peptide products is creating new opportunities for nutraceutical manufacturers.**...

[Read More](https://blog.lyfegroup.com/peptide-supplements-what-the-boom-means-for-manufacturers-lyfe-group-blog)

[![Empty Capsules Market Outlook 2026 | Lyfe Group](https://blog.lyfegroup.com/hubfs/image_blog-Empty_Capsules_2026_Industry_Outlook.jpg)](https://blog.lyfegroup.com/empty-capsules-market-outlook-2026-lyfe-group)

### [Empty Capsules: 2026 Industry Outlook](https://blog.lyfegroup.com/empty-capsules-market-outlook-2026-lyfe-group)

The **empty capsules market** continues to evolve as pharmaceutical and nutraceutical manufacturers respond to changing...

[Read More](https://blog.lyfegroup.com/empty-capsules-market-outlook-2026-lyfe-group)

[![Supplements for Longevity: A Business Guide | Lyfe Group](https://blog.lyfegroup.com/hubfs/image_blog-Supplements_for_Longevity_A_Business_Guide_to_the_Healthy_Aging_Supplement_Opportunity.jpg)](https://blog.lyfegroup.com/supplements-for-longevity-lyfe-group)

### [Supplements for Longevity: A Business Guide to the Healthy Aging Supplement Opportunity](https://blog.lyfegroup.com/supplements-for-longevity-lyfe-group)

The healthy aging category has evolved from a niche wellness segment into one of the most promising opportunities in...

[Read More](https://blog.lyfegroup.com/supplements-for-longevity-lyfe-group)

[![Empty Capsule Market Antidumping | CapsCanada](https://blog.lyfegroup.com/hubfs/image-blog-antidumping-ruling-reshapes-the-US-empty-capsule-market.jpg)](https://blog.lyfegroup.com/antidumping-ruling-reshapes-the-u.s.-empty-capsule-market)

### [Antidumping Ruling Reshapes the U.S. Empty Capsule Market](https://blog.lyfegroup.com/antidumping-ruling-reshapes-the-u.s.-empty-capsule-market)

The empty capsule market is entering a new phase. In February 2026, the [U.S. International Trade Commission (USITC)](https://www.usitc.gov/press_room/news_release/2026/er0116_67987.htm)...

[Read More](https://blog.lyfegroup.com/antidumping-ruling-reshapes-the-u.s.-empty-capsule-market)

[![Key Insights for the Supplement Industry | CapsCanada](https://blog.lyfegroup.com/hubfs/image-blog-supplement-industry-outlook-2026.jpg)](https://blog.lyfegroup.com/key-insights-for-the-supplement-industry-capscanada)

### [Supplement Industry Outlook 2026](https://blog.lyfegroup.com/key-insights-for-the-supplement-industry-capscanada)

The **supplement industry** enters 2026 with accelerated demand for targeted, science-backed solutions that support...

[Read More](https://blog.lyfegroup.com/key-insights-for-the-supplement-industry-capscanada)

[![Pharmaceutical Industry Trends 2026 | CapsCanada](https://blog.lyfegroup.com/hubfs/image-blog-pharmaceutical-Industry-trends-2026-shifts-redefining-the-future-of-pharma.jpg)](https://blog.lyfegroup.com/pharmaceutical-industry-trends-2026-capscanada)

### [Pharmaceutical Industry Trends 2026](https://blog.lyfegroup.com/pharmaceutical-industry-trends-2026-capscanada)

The pharmaceutical industry is entering one of its most dynamic phases. Demographic changes, scientific breakthroughs,...

[Read More](https://blog.lyfegroup.com/pharmaceutical-industry-trends-2026-capscanada)

[![ CapsCanada at SupplySide Global 2025](https://blog.lyfegroup.com/hubfs/image-blog-supply-side-global-2025.jpg)](https://blog.lyfegroup.com/capscanada-at-supplyside-global-2025)

### [CapsCanada at SupplySide Global 2025](https://blog.lyfegroup.com/capscanada-at-supplyside-global-2025)

SupplySide Global 2025, taking place on October 29 – 30, at Mandalay Bay, Las Vegas,  is one of the most important...

[Read More](https://blog.lyfegroup.com/capscanada-at-supplyside-global-2025)

[![Duties Impact Imports: important for capsule buyers | CapsCanada](https://blog.lyfegroup.com/hubfs/image-blog-anti-dumping-investigation-advances-what-it-means-for-capsule-buyers.jpg)](https://blog.lyfegroup.com/duties-impact-imports-important-for-capsule-buyers-capscanada)

### [Anti-Dumping Investigation Advances: What It Means for Capsule Buyers?](https://blog.lyfegroup.com/duties-impact-imports-important-for-capsule-buyers-capscanada)

After the U.S. government initiated an investigation of dumping capsules from a variety of countries, the Department of...

[Read More](https://blog.lyfegroup.com/duties-impact-imports-important-for-capsule-buyers-capscanada)

[![Capsules vs Tablets: 2025 Trends | CapsCanada](https://blog.lyfegroup.com/hubfs/image-blog-the-capsule-tablet-choice-in-2025-and-beyond-1.jpg)](https://blog.lyfegroup.com/the-capsule-tablet-choice-in-2025-and-beyond)

### [The Capsule-Tablet Choice in 2025 and Beyond](https://blog.lyfegroup.com/the-capsule-tablet-choice-in-2025-and-beyond)

Choosing the right solid oral dosage form is no longer just functional, it’s strategic. While tablets have long...

[Read More](https://blog.lyfegroup.com/the-capsule-tablet-choice-in-2025-and-beyond)

### Most Popular

Search more blogs by category

- [Market-Trends](https://blog.lyfegroup.com/tag/Market-Trends)
- [K-CAPS](https://blog.lyfegroup.com/tag/K-CAPS)
- [Corporate](https://blog.lyfegroup.com/tag/Corporate)
- [Knowledge-Center](https://blog.lyfegroup.com/tag/Knowledge-Center)
- [Capsule-Technology](https://blog.lyfegroup.com/tag/Capsule-Technology)
- [Technical-Services](https://blog.lyfegroup.com/tag/Technical-Services)
- [Banding-Kits](https://blog.lyfegroup.com/tag/Banding-Kits)
- [AR-CAPS](https://blog.lyfegroup.com/tag/AR-CAPS)
- [Delayed-Release-Capsules](https://blog.lyfegroup.com/tag/Delayed-Release-Capsules)
- [K-CAPS-Delayed-Release-Capsules](https://blog.lyfegroup.com/tag/K-CAPS-Delayed-Release-Capsules)
- [LQ-CAPS](https://blog.lyfegroup.com/tag/LQ-CAPS)
- [G-CAPS](https://blog.lyfegroup.com/tag/G-CAPS)
- [TiO2-Free](https://blog.lyfegroup.com/tag/TiO2-Free)
- [PET-CAPS](https://blog.lyfegroup.com/tag/PET-CAPS)
- [FLAVORED-CAPS](https://blog.lyfegroup.com/tag/FLAVORED-CAPS)

### Subscribe to our blog

[![Logo-LyfeGroup-blue](https://blog.lyfegroup.com/hubfs/Logo-LyfeGroup-blue.png "Logo-LyfeGroup-blue")](https://lyfegroup.com/)

Creating Capsules for Everyone

**Address**:  3236 sw 30th Ave Dania Beach, Fl 33312

**Phone:** [+1-800-440-6470](tel:+18004406470)

**Email** : [contact@lyfegroup.com](mailto:contact@lyfegroup.com)

<https://x.com/lyfegroupco> <https://www.linkedin.com/company/lyfegroupco> <https://www.youtube.com/@lyfe_group>

#### Sections

- [Industries](https://lyfegroup.com/markets/)
- [Products](https://lyfegroup.com/empty-capsules/)
- [Services](https://lyfegroup.com/services/)
- [Build Your Own Capsule](https://lyfegroup.com/capsule-customizer/)

#### Knowledge center

- [Blog](https://blog.lyfegroup.com/)
- [News and Events](https://lyfegroup.com/news-and-events/)
- [FAQs](https://lyfegroup.com/faqs/)

#### Subscribe

 

Don’t miss our latest news. Subscribe to our newsletter.

Lyfe Group Holdings, Inc. – All Rights reserved 2026

- [Home](https://lyfegroup.com/)
- [Terms](https://lyfegroup.com/terms-of-use/)
- [Privacy Policy](https://lyfegroup.com/privacy-policy/)
- [Contact](https://lyfegroup.com/contact/)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "CapsCanada",
    "url" : "https://blog.lyfegroup.com/author/capscanada"
  },
  "dateModified" : "2026-04-14T17:26:55.862Z",
  "datePublished" : "2021-11-11T16:30:00.000Z",
  "headline" : "The Promise of Antiviral COVID-19 Treatment Pills",
  "image" : [ "https://blog.lyfegroup.com/hubfs/50-mini-portada.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.lyfegroup.com/the-promise-of-antiviral-covid-19-treatment-pills",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.lyfegroup.com/hubfs/Logo-LyfeGroup-blue.png"
    },
    "name" : "LyfeGroup"
  }
}
```